Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116202395 | 11620239 | 5 | F | 20150828 | 20160901 | 20151012 | 20160906 | EXP | JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-068571 | BRISTOL MYERS SQUIBB | 87.00 | YR | F | Y | 0.00000 | 20160906 | PH | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116202395 | 11620239 | 1 | PS | ABILIFY | ARIPIPRAZOLE | 1 | Oral | 6 MG, QD | 510 | MG | Y | 21436 | 6 | MG | TABLET | QD | |||
| 116202395 | 11620239 | 2 | SS | ABILIFY | ARIPIPRAZOLE | 1 | Oral | 3 MG, QD | 510 | MG | Y | 21436 | 3 | MG | TABLET | QD | |||
| 116202395 | 11620239 | 3 | C | IRON | IRON | 1 | Unknown | UNK | U | 0 | |||||||||
| 116202395 | 11620239 | 4 | C | THYRADIN-S | LEVOTHYROXINE | 1 | Unknown | UNK | 0 | ||||||||||
| 116202395 | 11620239 | 5 | C | ARICEPT | DONEPEZIL HYDROCHLORIDE | 1 | Unknown | UNK | 0 | ||||||||||
| 116202395 | 11620239 | 6 | C | ROZEREM | RAMELTEON | 1 | Unknown | UNK | 0 | ||||||||||
| 116202395 | 11620239 | 7 | C | FESIN /00023550/ | IRON SUCROSE | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 116202395 | 11620239 | 1 | Mental disorder due to a general medical condition |
| 116202395 | 11620239 | 3 | Product used for unknown indication |
| 116202395 | 11620239 | 4 | Product used for unknown indication |
| 116202395 | 11620239 | 5 | Product used for unknown indication |
| 116202395 | 11620239 | 6 | Product used for unknown indication |
| 116202395 | 11620239 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 116202395 | 11620239 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 116202395 | 11620239 | Anaemia | |
| 116202395 | 11620239 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 116202395 | 11620239 | 1 | 20150605 | 20151027 | 0 | |
| 116202395 | 11620239 | 2 | 20151028 | 0 | ||
| 116202395 | 11620239 | 7 | 20150805 | 20150818 | 0 |